SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007873
Filing Date
2022-05-05
Accepted
2022-05-05 16:32:18
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rlay-20220331.htm   iXBRL 10-Q 2276781
2 EX-10.1 rlay-ex10_1.htm EX-10.1 37216
3 EX-10.2 rlay-ex10_2.htm EX-10.2 41047
4 EX-31.1 rlay-ex31_1.htm EX-31.1 21132
5 EX-31.2 rlay-ex31_2.htm EX-31.2 21072
6 EX-32.1 rlay-ex32_1.htm EX-32.1 19580
  Complete submission text file 0000950170-22-007873.txt   7110590

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20220331_lab.xml EX-101.LAB 346630
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20220331_pre.xml EX-101.PRE 251396
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20220331.xsd EX-101.SCH 37954
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlay-20220331_cal.xml EX-101.CAL 45605
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlay-20220331_def.xml EX-101.DEF 141705
47 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20220331_htm.xml XML 1295347
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 22896921
SIC: 2836 Biological Products, (No Diagnostic Substances)